Impact of allergic rhinitis control on work productivity and costs: a real-world data MASK-air study

Atopic Dermatitis

Real-world burden of atopic dermatitis: Austrian and Swiss data from the MEASURE-AD study

J Dermatolog Treat

Darbellay B, Huber M, Bisschoff IJ, Guillod C, Hügel R, Pirkhammer D, Sator PG, Taskesen T, Lang CCV

doi: 10.1080/09546634.2024.2415407

Psoriatic Arthritis

Patient profiles in randomised controlled trials versus a real-world study, in psoriatic arthritis: scoping review and meta-analysis

J Rheumatol

Alle G, Lopez-Medina C, Siebert S, Lavie F, Noel W, Smolen JS, Gossec L

doi: 10.3899/jrheum.2024-0653

Further Publications Immunology

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study

J Eur Acad Dermatol Venereol

Nikolaou V, Panou E, Tsimpidakis A, Koumprentziotis IA, Patsatsi A, Siakantaris M, Kruger-Krasagakis SE, Marinos L, Georgiou E, Lampadaki K, Velissari A, Daponte AI, Doxastaki A, Kaliampou S, Vaiopoulos A, Konstandinou I, Koumourtzis M, Lakiotaki E, Pappa V, Tsamaldoupis A, Stratigos A, Papadavid E

doi: 10.1111/jdv.20350

Psoriatic Arthritis

The Impact of Early Attainment of Minimal Disease Activity on Radiographic Outcomes: A Real-World Longitudinal Cohort Study in Psoriatic Arthritis

J Rheumatol

Koc GH, Kok MR, Snoeck Henkemans SVJ, Luime JJ, Tchetverikov I, van der Kaap JH, Baudoin P, Kok P, Goekoop-Ruiterman YPM, Vos PAJM, van Oosterhout M, Korswagen LA, Dolhain RJEM, Vis M

doi: 10.3899/jrheum.2024-1162

Psoriasis

Real-world Cost per Responder Among Different Classes of Biologics for the Treatment of Psoriasis

Acta Derm Venereol

Godding LTH, Seyger MMB, Duvetorp A, Otero ME, Ossenkoppele PM, Oostveen AM, Visch MB, Van der Voort EAM, Körver JEM, Weppner-Parren LJMT, Berends MAM, Arnold WP, Dodemont SRP, Kuijpers ALA, Mommers JM, Homan FM, Gostynski AH, Velstra B, Kleinpenning MM, Van Doorn MBA, Keijsers RRMC, Kop EN, Haeck IM, Hendricksen-Roelofzen JHJ, Vellinga D, De Jong EMGJ, Van den Reek JMPA

doi: 10.2340/actadv.v105.42767

Psoriatic Arthritis

Bimekizumab Improves Patient-Reported Outcomes and Work Productivity in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies

J Rheumatol

Gladman DD, Mease PJ, Gossec L, Husni ME, Gottlieb AB, Ink B, Bajracharya R, Coarse J, Lyris N, Lambert J, Tillett W

doi: 10.3899/jrheum.2024-0923

Atopic Dermatitis

Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study

Acta Derm Venereol

Calabrese L, Cinotti E, D'Onghia M, Cartocci A, Rubegni P, Maccari F, Boulard C, Reguiai Z, Becherel PA, Jacobzone C, Begon E, Fite C, Walls B, Liegeon AL, Parier J, Chaby G, Perrot JL, Omcci Group

doi: 10.2340/actadv.v105.42275

Further Publications Immunology

Real-world Effectiveness of Lanadelumab in Hereditary Angioedema: Multi-country INTEGRATED Observational Study

J Allergy Clin Immunol Pract

Magerl M, Bouillet L, Martinez-Saguer I, Gavini F, Bent-Ennakhil N, Sayegh L, Andresen I

doi: 10.1016/j.jaip.2024.12.008

Psoriatic Arthritis

Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium

Ann Rheum Dis

Karmacharya P, Crofford LJ, Byrne DW, Stephens-Shields A, Husni ME, Scher JU, Craig E, Fitzsimmons R, Reddy SM, Magrey MN, Walsh JA, Ogdie A

doi: 10.1136/ard-2024-226150

Related content

Real-world burden of atopic dermatitis: Austrian and Swiss data from the MEASURE-AD study

Patient profiles in randomised controlled trials versus a real-world study, in psoriatic arthritis: scoping review and meta-analysis

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study

The Impact of Early Attainment of Minimal Disease Activity on Radiographic Outcomes: A Real-World Longitudinal Cohort Study in Psoriatic Arthritis

Real-world Cost per Responder Among Different Classes of Biologics for the Treatment of Psoriasis

Bimekizumab Improves Patient-Reported Outcomes and Work Productivity in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies

Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study

Real-world Effectiveness of Lanadelumab in Hereditary Angioedema: Multi-country INTEGRATED Observational Study

Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium